av/acelrx-pharmaceuticals--big.svg

NASDAQ:ACRX

AcelRx Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.80

09/01 21:00

Market Cap

14.58M

Beta: 0.24

Volume Today

241.00K

Avg: 223.92K

PE Ratio

−1.83

PFCF: −0.68

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
233K
-
1.31M
462.23%
1.55M
18.70%
905K
41.80%
2.07M
129.23%
2.46M
18.61%
1.37M
44.38%
1.14M
16.37%
589K
48.54%
average payables
2.29M
-
2.39M
4.28%
2.00M
16.35%
1.56M
21.87%
1.49M
4.39%
1.75M
17.17%
1.90M
8.47%
2.23M
17.60%
2.43M
9.00%
2.08M
14.35%
1.69M
18.87%
average receivables
1.64M
-
4.56M
177.51%
3.68M
19.22%
967K
73.74%
460.50K
52.38%
577.50K
25.41%
397.50K
31.17%
234.50K
41.01%
154.50K
34.12%
book value per share
36.81
-
21.49
41.63%
14.95
30.43%
-2.36
115.76%
-15.57
561.16%
1.46
109.35%
-10.46
818.34%
-13.08
25.02%
-5.99
54.20%
2.95
149.32%
0.00
99.97%
capex per share
-1.65
-
-2.54
53.28%
-0.66
74.07%
-1.64
149.78%
-1.03
37.52%
-0.28
72.67%
-0.88
212.52%
-0.44
50.35%
-0.30
29.94%
-0.05
83.83%
-0.00
99.99%
capex to depreciation
-5.54
-
-6.36
14.68%
-0.73
88.46%
-1.81
147.03%
-1.38
23.93%
-1.42
3.29%
-2.08
46.06%
-1.00
51.88%
-0.93
7.50%
-0.22
76.13%
-0.32
45.49%
capex to operating cash flow
6.75
-
0.16
97.63%
0.07
54.33%
0.13
73.43%
0.08
36.15%
0.03
65.14%
0.07
140.69%
0.05
28.94%
0.06
26.40%
0.01
78.90%
0.01
55.50%
capex to revenue
-0.11
-
-1.06
847.08%
-0.08
92.84%
-0.21
183.55%
-0.30
40.36%
-0.38
26.57%
-1.52
298.14%
-0.34
77.41%
-0.65
89.29%
-0.21
68.30%
-0.15
25.26%
cash per share
52.16
-
34.70
33.47%
51.23
47.62%
35.45
30.80%
25.80
27.23%
36.20
40.33%
16.70
53.85%
10.06
39.77%
8.62
14.37%
2.14
75.21%
0.00
99.97%
days of inventory on hand
96.10
-
63.84
33.56%
32.74
48.72%
78.40
139.48%
176.71
125.40%
98.39
44.32%
108.05
9.82%
165.95
53.58%
days payables outstanding
321.90
-
46.18
85.65%
48.76
5.60%
190.03
289.70%
92.24
51.46%
165.62
79.55%
206.28
24.55%
287.38
39.32%
days sales outstanding
62.26
-
122.66
97.00%
69.99
42.94%
68.05
2.77%
82.92
21.86%
42.79
48.39%
20.72
51.57%
63.68
207.30%
debt to assets
0.13
-
0.29
120.69%
0.16
43.17%
0.22
31.62%
0.25
17.28%
0.10
60.64%
0.33
227.42%
0.39
18.55%
0.24
38.09%
0.22
8.19%
debt to equity
0.20
-
0.53
171.88%
0.63
18.37%
-4.04
739.04%
-0.52
87.05%
2.82
639.04%
-0.72
125.48%
-0.46
36.09%
-0.52
12.98%
0.48
192.10%
dividend yield
earnings yield
-0.05
-
-0.11
118.99%
-0.14
25.36%
-0.37
156.06%
-0.54
47.74%
-0.35
35.43%
-0.32
8.81%
-0.38
19.86%
-0.52
36.91%
2.86
647.15%
-0.00
100.03%
enterprise value
375.50M
-
257.13M
31.52%
83.56M
67.50%
59.05M
29.32%
61.37M
3.92%
58.94M
3.96%
182.15M
209.05%
104.04M
42.88%
73.08M
29.76%
11.84M
83.80%
10.48B
88,406.05%
enterprise value over ebitda
-17.14
-
-8.61
49.74%
-5.39
37.40%
-2.04
62.22%
-1.68
17.31%
-1.70
1.15%
-3.50
105.42%
-2.81
19.82%
-2.37
15.54%
-0.39
83.45%
-620.41
158,072.66%
ev to operating cash flow
-771.04
-
-7.46
99.03%
-4.19
43.89%
-2.01
52.03%
-2.06
2.63%
-2.03
1.68%
-3.56
75.57%
-2.70
24.08%
-2.44
9.85%
-0.42
82.84%
-599.02
143,249.24%
ev to sales
12.73
-
49.29
287.24%
4.34
91.20%
3.40
21.56%
7.68
125.61%
27.40
256.98%
79.58
190.42%
19.21
75.86%
25.93
35.00%
6.68
74.22%
16.10K
240,674.52%
free cash flow per share
-1.90
-
-18.40
869.11%
-9.67
47.48%
-14.62
51.22%
-13.72
6.11%
-10.24
25.41%
-13.80
34.85%
-9.47
31.41%
-5.31
43.90%
-3.89
26.84%
-0.00
99.97%
free cash flow yield
-0.01
-
-0.14
1,528.63%
-0.13
8.19%
-0.28
123.92%
-0.34
20.26%
-0.22
34.45%
-0.33
47.63%
-0.38
16.72%
-0.47
24.21%
-1.72
262.55%
-0.00
99.90%
graham net net
33.61
-
16.38
51.27%
9.70
40.76%
-8.64
189.02%
-21.31
146.78%
-3.37
84.20%
-16.32
384.39%
-18.27
11.96%
-10.26
43.84%
-1.23
88.01%
0.00
100.02%
graham number
98.81
-
86.18
12.79%
60.87
29.36%
31.77
47.80%
87.75
176.16%
23.00
73.79%
56.26
144.61%
52.79
6.16%
28.09
46.79%
20.73
26.21%
0.00
99.98%
income quality
0.02
-
1.03
4,869.34%
0.82
20.84%
0.68
16.71%
0.58
15.16%
0.62
6.71%
0.96
55.89%
0.95
0.80%
0.85
10.36%
-0.59
169.40%
0.95
260.27%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0.19
Infinity%
0
100%
interest coverage
-4.39
-
-14.27
224.83%
-3.69
74.12%
-2.63
28.77%
-2.76
4.79%
-2.84
3.24%
-45.25
1,490.40%
-12.39
72.61%
-15.70
26.66%
-31.77
102.39%
126.04
496.69%
interest debt per share
7.99
-
12.69
58.73%
11.89
6.30%
14.87
25.15%
14.13
4.98%
8.41
40.53%
7.82
6.99%
6.78
13.28%
3.49
48.54%
1.57
55.08%
-0.00
100.00%
inventory turnover
3.80
-
5.72
50.52%
11.15
95.02%
4.66
58.24%
2.07
55.63%
3.71
79.60%
3.38
8.94%
2.20
34.89%
invested capital
0.20
-
0.53
171.88%
0.63
18.37%
-4.04
739.04%
-0.52
87.05%
2.82
639.04%
-0.72
125.48%
-0.46
36.09%
-0.52
12.98%
0.48
192.10%
market cap
449.53M
-
292.26M
34.99%
170.56M
41.64%
117.81M
30.92%
95.17M
19.22%
134.92M
41.77%
167.08M
23.83%
105.72M
36.73%
67.12M
36.51%
16.69M
75.13%
10.48B
62,711.83%
net current asset value
66.79M
-
36.51M
45.34%
24.27M
33.51%
-16.28M
167.05%
-48.65M
198.88%
-8.29M
82.97%
-61.09M
637.22%
-75.22M
23.13%
-58.30M
22.49%
-1.11M
98.10%
5.27M
575.70%
net debt to ebitda
3.38
-
1.18
65.17%
5.62
377.04%
2.03
63.90%
0.93
54.22%
2.20
136.71%
-0.29
113.19%
0.05
115.60%
-0.19
527.70%
0.16
183.18%
0.34
110.72%
net income per share
-11.79
-
-15.36
30.31%
-11.02
28.29%
-19.05
72.93%
-21.97
15.35%
-16.14
26.52%
-13.45
16.71%
-9.47
29.56%
-5.86
38.17%
6.47
210.41%
-0.00
100.01%
operating cash flow per share
-0.25
-
-15.87
6,375.54%
-9.01
43.23%
-12.97
44.03%
-12.70
2.13%
-9.96
21.59%
-12.93
29.84%
-9.03
30.12%
-5.01
44.58%
-3.84
23.37%
-0.00
99.97%
payables turnover
1.13
-
7.90
597.10%
7.49
5.30%
1.92
74.34%
3.96
106.01%
2.20
44.30%
1.77
19.71%
1.27
28.22%
receivables turnover
5.86
-
2.98
49.24%
5.22
75.26%
5.36
2.85%
4.40
17.94%
8.53
93.76%
17.61
106.50%
5.73
67.46%
research and ddevelopement to revenue
0.89
-
4.70
427.38%
1.17
75.16%
1.23
5.62%
2.43
96.88%
6.11
151.58%
2.04
66.66%
0.74
63.58%
1.45
95.92%
2.93
101.78%
8.52
190.54%
return on tangible assets
-0.21
-
-0.39
81.22%
-0.19
50.51%
-0.43
126.04%
-0.68
57.96%
-0.39
42.62%
-0.58
48.98%
-0.61
4.51%
-0.45
26.02%
1.24
374.08%
-0.50
140.84%
revenue per share
14.85
-
2.40
83.82%
8.70
261.96%
7.66
11.91%
3.41
55.48%
0.74
78.40%
0.58
21.50%
1.27
119.76%
0.47
62.99%
0.24
49.00%
0.00
99.98%
roe
-0.32
-
-0.71
123.25%
-0.74
3.07%
8.09
1,197.44%
1.41
82.55%
-11.09
885.78%
1.29
111.60%
0.72
43.65%
0.98
35.01%
2.19
123.87%
-0.73
133.31%
roic
-0.03
-
-0.64
2,045.31%
-0.38
40.02%
-1.97
416.76%
2.19
211.27%
-2.20
200.36%
7.69
449.54%
1.55
79.84%
2.89
86.31%
-0.99
134.37%
-1.20
20.63%
sales general and administrative to revenue
0.33
-
3.52
950.38%
0.74
79.03%
0.90
21.87%
2.08
131.18%
9.65
364.69%
shareholders equity per share
36.81
-
21.49
41.63%
14.95
30.43%
-2.36
115.76%
-15.57
561.16%
1.46
109.35%
-10.46
818.34%
-13.08
25.02%
-5.99
54.20%
2.95
149.32%
0.00
99.97%
stock based compensation to revenue
0.12
-
0.85
621.70%
0.26
69.44%
0.26
0.78%
0.54
108.13%
2.40
347.34%
2.21
8.05%
0.82
63.03%
1.64
100.23%
1.63
0.26%
2.66
62.81%
tangible asset value
73.16M
-
46.66M
36.23%
33.11M
29.03%
-5.34M
116.12%
-36.51M
584.07%
4.25M
111.65%
-41.42M
1,073.85%
-55.75M
34.60%
-35.89M
35.62%
12.99M
136.20%
14.11M
8.54%
tangible book value per share
36.81
-
21.49
41.63%
14.95
30.43%
-2.36
115.76%
-15.57
561.16%
1.46
109.35%
-10.46
818.34%
-13.08
25.02%
-5.99
54.20%
1.76
129.38%
0.00
99.94%
working capital
96.80M
-
62.57M
35.36%
106.17M
69.69%
78.86M
25.72%
49.75M
36.91%
92.07M
85.05%
58.08M
36.92%
29.20M
49.73%
36.98M
26.67%
10.80M
70.81%
7.04M
34.75%

All numbers in USD (except ratios and percentages)